Hi gilesy71,I notice your first thread was dated 17 Sept 2019...

Hi gilesy71,

I notice your first thread was dated 17 Sept 2019 yet your calling yourself a LTH. When did you become a SH in GMV?? In defence of my fellow HC members, I would say that we are positive posters not uprampers or fantasyland crew. We assist each other in doing research, chasing down leads and posting the information for all to read.

I have been a SH in GMV since Jul 2017 and yes I was drawn in by the proposed 1 Billion in lucrative Mou's and the entry into China. Dr Yacov in early 2018 made a highly professional presentation to delegates from China and even with China's significant barriers of entry to foreign countries, he was able to gain the "green channel". This pathway to success, was meant to expedite the approval process, unfortunately it would appear that we were given the wrong information and as a consequence the approval process has blown out.

The CFDA/NMPA was and still is one of the major growth driver's for the Prizma Jacket & GMed Patch. Why wouldn't SH's be jumping for joy with what had been dressed up and put on a plate in front of us. Hind sight is always a great tool and I'm 100% sure that given the chance the roadmap to success would've been completely different.

I completely agree with you regarding the need for some positive announcements. GMV had a swag of good announcements but no mention of revenue. This time as opposed to 2017 is completely different. In 2017 the Mou's had an attached 1 Billion price tag and alot of empty promises whereas the current period with old mate Covid-19, has everyone jumping at their shadows. The Covid-19 is GMV's opportunity to showcase the Prizma & GMed Patch and demonstrate their capabilities.

Dr G and his team have been working extremely hard to rollout their products globally. Here are some recent announcements highlighting future revenue building contracts in Age Care Facilities in USA/AUS/NZ. With the world currently in the biggest Pandemic since 1918, the use of Telehealth Procedures for Dr's, and Remote Monitoring for Hospitals & Aged Care Domicile's.


a. All Country Health Care (USA)
b. HSC Partners & Vital Signs Platform (USA)
c. Live Care/Homestay Care uVue Telehealth (Aus/NZ

With regard to the amount of shares issued and also the price, Dr Yacov was backed into a corner and had to sell that many shares to cover the debt to MAGNA which was due. The biggest positive to come out of the issue of new shares, was that GMV is now debt free and the books are clear.

What does GMV have to look forward too in the next 6mths:
a. Nasdaq listing possibly Aug/Sept 2020
b. FDA Approval GMed Patch
c. Sales from OTC sales for Prizma in USA
d. Sales from Taiwan/India
e. Sales in Aust/NZ
f. NMPA Approval
g. Sales from OTC Italy
h. Possible HKZE in 2021

GMV has a fantastic product that needs to be showcased to the world and the company especially needs word of mouth, due to the lack of sales personnel. The world will grasp this virus and when all the different countries do their "Post Pandemic Report", one of the major recommendations will be the use of Telehealth and Remote Monitoring.

GMV is a jewel in the rough just waiting to be spit polished to gain the maximum benefit. GMV will be a global player in the EHealth for years to come.

My apologies if I have ranted, just clearing the head because it's Saturday.

Cheers Rubes